Prof. Dr. A (Ton) Hagenbeek (1948 – 2021)
17 May 2021
Professor of Hematology, Academic Medical Center (AMC) , Dept. of Hematology , University of Amsterdam.
Today, the international community has lost a true leader in the field of hematology. Prof. Hagenbeek has touched and inspired many doctors and scientists in carrying out the best cancer care and research for patients. His boundless enthusiasm and commitment have helped many organisations to drive new innovations in cancer care.
It is with great sadness that we learn the death of Professor Hagenbeek. EORTC has lost a major contributor to its scientific agenda and a peer. Professor Hagenbeek has been leading many EORTC studies in the field of lymphoma research which have made a difference for patients, as well as acting as a true leader for the EORTC Lymphoma group. His vision and dedication to hematology, collaborating across the world, positioned him as a pioneer in clinical research already in the years 80s.
We will remember Professor Hagenbeek as a generous, passionate and talented scientist, doctor and clinical investigator, always going the extra mile, pushing relentlessly the boundaries of therapeutic progress for cancer patients.
Related News
Meet the new EORTC Board
9 Jul 2024
We are pleased to announce the release of the EORTC 2023 Annual Report
17 Jun 2024
Dr Denis Lacombe, EORTC CEO, appointed stakeholder co-chair of ACT EU advisory group
24 May 2024
Clinical Trials Day 2024: a Q&A on pragmatic clinical trials
20 May 2024
EORTC/EMA workshop suggests an international way forward for treatment optimisation studies
8 May 2024
EORTC’s Participation at the ESTRO Congress 2024
29 Apr 2024
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024